Cash Balance of $102 million or approximately $1.15 per share as of March 31st Positioned for Strategic Initiatives and Technology Development NEW YORK, May 11, 2021 /PRNewswire/ -- AIkido Pharma Inc.
NEW YORK, April 16, 2021 /PRNewswire/ — AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today noted that a recent study announced positive early results from a PSMA 617-Lu177 study ...
NEW YORK, Feb. 1, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced that the Company executed a Two Million Dollar Convertible Promissory Note Purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results